former novartis exec to lead cambridge diabetes startup semma.

schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals.".

.

find this comment offensive?

.

.

did you know?

unleash the power of sip - invest in mutual funds

. to see how we safeguard and use the information you provide us with. if your facebook account does not have an attached e-mail address, you'll need to add that before you can sign up..

.